Literature DB >> 1658555

Use of erbstatin as protein-tyrosine kinase inhibitor.

K Umezawa, M Imoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658555     DOI: 10.1016/0076-6879(91)01034-y

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  4 in total

Review 1.  Thom Award Lecture. Trends in the search for bioactive microbial metabolites.

Authors:  S Omura
Journal:  J Ind Microbiol       Date:  1992-09

2.  Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation.

Authors:  Nicolas Foray; Didier Marot; Voahangy Randrianarison; Nicole Dalla Venezia; Didier Picard; Michel Perricaudet; Vincent Favaudon; Penny Jeggo
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets.

Authors:  J C Jonas; T D Plant; P Gilon; P Detimary; M Nenquin; J C Henquin
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

4.  Inhibition of ErbB kinase signalling promotes resolution of neutrophilic inflammation.

Authors:  Stephen A Renshaw; Lynne R Prince; Atiqur Rahman; Katherine M Henry; Kimberly D Herman; Alfred Ar Thompson; Hannah M Isles; Claudia Tulotta; David Sammut; Julien Jy Rougeot; Nika Khoshaein; Abigail E Reese; Kathryn Higgins; Caroline Tabor; Ian Sabroe; William J Zuercher; Caroline O Savage; Annemarie H Meijer; Moira Kb Whyte; David H Dockrell
Journal:  Elife       Date:  2019-10-15       Impact factor: 8.140

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.